Post-antifungal effects of the antifungal compound 2-(3,4-dimethyl-2,5- dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate on Aspergillus fumigatus

Journal of Medical Microbiology

Volumn 56, Issue 6, 2007, Pages 815-818

  Dabur, Rajesh ^a   Mandal, T K ^a   Sharma, G L ^b  

^a Regional Research Institute (Ay)   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3,4 DIMETHYL 2,5 DIHYDRO 1H PYRROL 2 YL) 1 METHYLETHYLPENTANOATE; AMPHOTERICIN B; ANTIFUNGAL AGENT; FUNGAL PROTEIN; FUNGUS ANTIGEN; METALLOPROTEINASE; PYRROLE DERIVATIVE; SECRETORY PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIFUNGAL ACTIVITY; ANTIGEN EXPRESSION; ARTICLE; ASPERGILLUS FUMIGATUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS CULTURE; FUNGUS GROWTH; GROWTH CURVE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; POSTANTIBIOTIC EFFECT; POSTANTIFUNGAL EFFECT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TURBIDIMETRY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; FUNGAL PROTEINS; HUMANS; METALLOPROTEASES; MOLECULAR WEIGHT; PYRROLES; VALERATES; VIRULENCE FACTORS;

EID: 34250360313     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47120-0     Document Type: Article

References (17)

1. Boogaerts, M., Maertens, J., van Hoof, A., de Bock, R., Fillet, G., Peetermans, M, Selleslag, D., Vandercam, B., Vandewoude, K. & other authors (2001). Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients. J Antimicrob Chemother 48, 97-103.
2. Dabur, R., Ali, M., Singh, H., Gupta, J. & Sharma, G. L. (2004). A novel antifungal pyrrole derivative from Datura metel leaves. Pharmazie 59, 568-570.
3. Dabur, R., Chhillar, A. K., Yadav, V., Kamal, P. K., Gupta, J. & Sharma, G. L. (2005a). In vitro antifungal activity of 2-(3,4-dimethyl-2, 5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate, a dihydropyrrole derivative. J Med Microbiol 54, 549-552.
4. Dabur, R., Diwedi, S. K., Yadav, V., Mishra, V., Singh, R., Singh, H. & Sharma, G. L. (2005b). Efficacy of 2-(3,4-dimethyl-2,5-dihydro-1H- pyrrole-2-yl)-1-methylethyl pentanoate in a murine model of invasive aspergillosis. Antimicrob Agents Chemother 49, 4365-4367.
5. Dannaoui, E., Borel, E., Persat, F., Monier, M. F. & Piens, M. A. (1999). In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus. J Med Microbiol 48, 1087-1093.
6. Ernst, E. J., Klepser, M. E. & Pfaller, M. A. (2000). Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans. Antimicrob Agents Chemother 4, 1108-1111.
7. Kaiser, L., Huguenin, T., Lew, P. D., Chapuis, B. & Pittet, D. (1998). Invasive aspergillosis. Clinical features of 35 proven cases at a single institution. Medicine (Baltimore) 77, 188-194.
8. Langfelder, K., Jahn, B., Gehringer, H., Schmidt, A., Wanner, G. & Brakhage, A. A. (1998). Identification of a polyketide synthasegene (pksP) of Aspergillus fumigatus involved in conidial pigment biosynthesis and virulence. Med Microbiol Immunol 187, 79-89.
9. Langfelder, K., Streibel, M., Jahn, B., Haase, G. & Brakhage, A. A. (2003). Biosynthesis of fungal melanins and their importance for human pathogenic fungi. Fungal Genet Biol 38, 143-158.
10. Lin, S. J., Schranz, J. & Teutsch, S. M. (2001). Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32, 358-366.
11. Markaryan, A., Morozova, I., Yu, H. & Kollattukudy, P. E. (1994). Purification and characterization of an elastinolytic metalloprotease from Aspergillus fumigatus and immunoelectron microscope evidence for the secretion of this enzyme by fungus invading the murine lung. Infect Immun 62, 2149-2157.
12. Minguez, F., Chiu, M. L., Lima, J. E., Nique, R. & Prieto, J. (1994). Activity of fluconazole: postantifungal effect, effects of low concentrations and of pretreatment on the susceptibility of Candida albicans to leucocytes. J Antimicrob Chemother 34, 93-100.
13. Mylonakis, E., Barlam, T. F., Flanigan, T. & Rich, J. D. (1998). Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. Chest 114, 251-262.
14. National Committee for Clinical Laboratory Standards (1998). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; approved standard, document M38-P. Wayne, PA: National Committee for Clinical Laboratory Standards.
15. Sirakova, T. D., Markaryan, A. & Kollattukudy, P. E. (1994). Molecular cloning and sequencing of the cDNA and gene for a novel elastinolytic metalloproteinase from Aspergillus fumigatus and its expression in Escherichia coli. Infect Immun 62, 4208-4218.
16. Turnidge, J. D., Gudmundsson, S., Vogelman, B. & Craig, W. A. (1994). The postantibiotic effect of antifungal agents against common pathogenic yeasts. J Antimicrob Chemother 34, 83-92.
17. Vitale, R. G., Mouton, J. W., Afeltra, J., Meis, J. F. & Verweij, P. E. (2002). Method for measuring postantifungal effect in Aspergillus species. Antimicrob Agents Chemother 46, 1960-1965.